Perspective Therapeutics, Inc. - COMMON STOCK (CATX)

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
73,943,049
Total 13F shares
42,232,957
Share change
-2,042,794
Total reported value
$145,284,060
Put/Call ratio
0%
Price per share
$3.44
Number of holders
95
Value change
+$679,387
Number of buys
47
Number of sells
45

Institutional Holders of Perspective Therapeutics, Inc. - COMMON STOCK (CATX) as of Q2 2025

As of 30 Jun 2025, Perspective Therapeutics, Inc. - COMMON STOCK (CATX) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,232,957 shares. The largest 10 holders included FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Nuveen, LLC, Avidity Partners Management LP, MORGAN STANLEY, Nicholson Wealth Management Group, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.